|
1
|
Nguyen ATM and Holland AJA: Balanitis
xerotica obliterans: An update for clinicians. Eur J Pediatr.
179:9–16. 2020.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Das S and Tunuguntla HS: Balanitis
xerotica obliterans-a review. World J Urol. 18:382–387.
2000.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Celis S, Reed F, Murphy F, Adams S,
Gillick J, Abdelhafeez AH and Lopez PJ: Balanitis xerotica
obliterans in children and adolescents: A literature review and
clinical series. J Pediatr Urol. 10:34–39. 2014.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Dickie RJ, Horne CH, Sutherland HW,
Bewsher PD and Stankler L: Direct evidence of localized immunologic
damage in lichen sclerosus et atrophicus. J Clin Pathol.
35:1395–1399. 1982.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Meyrick Thomas RH, Ridley CM and Black MM:
The association of lichen sclerosus atrophicus and
autoimmune-related disease in males. Br J Dermatol. 109:661–664.
1983.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Fujiwara H, Fujiwara K, Hashimoto K,
Mehregan AH, Schaumburg-Lever G, Lange R, Schempp C and Gollnick H:
Detection of Borrelia burgdorferi DNA (B. garinii or B. afzelii) in
morphoea and lichen sclerosus et atrophicus tissue of German and
Japanese but not of US patients. Arch Dermatol. 133:41–44.
1997.PubMed/NCBI
|
|
7
|
Mazzoni D, Pool L and Muir J:
Pathologically oriented descriptive study of male genital
circumcisions across medical and surgical specialties. Int J
Dermatol. 60:559–563. 2021.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Boksh K and Patwardhan N: Balanitis
xerotica obliterans: Has its diagnostic accuracy improved with
time? JRSM Open. 8(2054270417692731)2017.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Pradhan A, Patel R, Said AJ and Upadhyaya
M: 10 years' experience in balanitis xerotica obliterans: A
single-institution study. Eur J Pediatr Surg. 29:302–306.
2019.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Fergus KB, Lee AW, Baradaran N, Cohen AJ,
Stohr BA, Erickson BA, Mmonu NA and Breyer BN: Pathophysiology,
clinical manifestations, and treatment of lichen sclerosus: A
systematic review. Urology. 135:11–19. 2020.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Clouston D, Hall A and Lawrentschuk N:
Penile lichen sclerosus (balanitis xerotica obliterans). BJU Int.
108 (Suppl 2):S14–S19. 2011.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Philippou P, Shabbir M, Ralph DJ, Malone
P, Nigam R, Freeman A, Muneer A and Minhas S: Genital lichen
sclerosus/balanitis xerotica obliterans in men with penile
carcinoma: A critical analysis. BJU Int. 111:970–976.
2013.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Buechner SA: Common skin disorders of the
penis. BJU Int. 90:498–506. 2002.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Folaranmi SE, Corbett HJ and Losty PD:
Does application, of topical steroids for lichen sclerosus
(balanitis xerotica obliterans) affect the rate of circumcision? A
systematic review. J Pediatr Surg. 53:2225–2227. 2018.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Hofer MD, Meeks JJ, Mehdiratta N, Granieri
MA, Cashy J and Gonzalez CM: Lichen sclerosus in men is associated
with elevated body mass index, diabetes mellitus, coronary artery
disease, and smoking. World J Urol. 32:105–108. 2014.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Kyriakis KP, Emmanuelides S, Terzoudi S,
Palamaras I, Damoulaki E and Evangelou G: Gender and age prevalence
distributions of morphea en plaque and anogenital lichen sclerosus.
J Eur Acad Dermatol Venereol. 21:825–826. 2007.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Kreuter A, Kryvosheyeva Y, Terras S,
Moritz R, Möllenhoff K, Altmeyer P, Scola N and Gambichler T:
Association of autoimmune diseases with lichen sclerosus in 532
male and female patients. Acta Derm Venereol. 93:238–241.
2013.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Nair PA: Vulvar lichen sclerosus et
atrophicus. J Midlife Health. 8:55–62. 2017.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Virgili A, Borghi A, Cazzaniga S, Di
Landro A, Naldi L, Minghetti S, Verrone A, Stroppiana E, Caproni M,
Nasca MR, et al: New insights into potential risk factors and
associations in genital lichen sclerosus: Data from a multicentre
Italian study on 729 consecutive cases. J Eur Acad Dermatol
Venereol. 31:699–704. 2017.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Lee A and Fischer G: Diagnosis and
treatment of vulvar lichen sclerosus: An update for dermatologists.
Am J Clin Dermatol. 19:695–706. 2018.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Kirtschig G: Lichen sclerosus: Symptoms,
diagnosis, therapeutic procedures. Hautarzt. 69:127–133.
2018.PubMed/NCBI View Article : Google Scholar : (In German).
|
|
22
|
Kirtschig G, Becker K, Günthert A,
Jasaitiene D, Cooper S, Chi CC, Kreuter A, Rall KK, Aberer W,
Riechardt S, et al: Evidence-based (S3) Guideline on (anogenital)
Lichen sclerosus. J Eur Acad Dermatol Venereol. 29:e1–e43.
2015.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Chung ASJ and Suarez OA: Current treatment
of lichen sclerosus and stricture. World J Urol. 38:3061–3067.
2020.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Tran DA, Tan X, Macri CJ, Goldstein AT and
Fu SW: Lichen sclerosus: An autoimmunopathogenic and genomic enigma
with emerging genetic and immune targets. Int J Biol Sci.
15:1429–1439. 2019.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Tatu AL and Nwabudike LC: The treatment
options of male genital Lichen sclerosus et atrophicus: Treatments
of genital Lichen sclerosus. In: Proceedings of the 14th National
Congress of Urogynecology and the National Conference of the
Romanian Association for the Study of Pain, Eforie, pp262-264,
2017.
|
|
26
|
Mautz TT, Krapf JM and Goldstein AT:
Topical corticosteroids in the treatment of vulvar lichen
sclerosus: A review of pharmacokinetics and recommended dosing
frequencies. Sex Med Rev. 10:42–52. 2022.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Bizjak Ogrinc U, Senčar S, Luzar B and
Lukanović A: Efficacy of non-ablative laser therapy for lichen
sclerosus: A randomized controlled trial. J Obstet Gynaecol Can.
41:1717–1725. 2019.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Tatu AL and Nwabudike LC: Male genital
lichen sclerosus-a permanent therapeutic challenge. J Am Acad
Dermatol. 79 (Suppl 1)(AB185)2018.
|
|
29
|
Fekete GL, Cotoi OS and Fekete JE:
Multiple nodular cutaneous metastasis as first clinical sign of
signet ring cell gastric carcinoma: Case report. Acta
Dermatovenerol Croat. 20:34–37. 2012.PubMed/NCBI
|
|
30
|
Neill SM, Tatnall FM and Cox NH: British
Association of Dermatologists. Guidelines for the management of
lichen sclerosus. Br J Dermatol. 147:640–649. 2002.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Bleeker MC, Visser PJ, Overbeek LI, Van
Beurden M and Berkhof J: Lichen sclerosus: Incidence and risk of
vulvar squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev.
25:1224–1230. 2016.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Powell J, Robson A, Cranston D,
Wojnarowska F and Turner R: High incidence of lichen sclerosus in
patients with squamous cell carcinoma of the penis. Br J Dermatol.
145:85–89. 2001.PubMed/NCBI View Article : Google Scholar
|
